Skip to main content
. 2022 Jan 23;14(3):493. doi: 10.3390/nu14030493

Figure 4.

Figure 4

HepG2 cells were treated with MOMAST® (50.0 μg/mL) and Pravastatin (Prav) 1.0 μM for 24 h. The percentage of LDLR protein level was measured by ICW (Panel (A)). The data points represent the averages ± SD of three experiments in duplicate. (****) p < 0.0001 vs. control (C). (Panel (B)) Effect of MOMAST® on the HepG2 cell ability to uptake LDL. The data points represent the averages ± SD of three experiments in triplicate. ns: not significant, (**) p < 0.01, and (***) p < 0.001 vs. control (C). LDLR: low-density lipoprotein receptor, LDL: low-density lipoprotein.